06:21 AM EDT, 10/23/2024 (MT Newswires) -- Thermo Fisher Scientific ( TMO ) reported Q3 adjusted earnings Wednesday of $5.28 per diluted share, down from $5.69 a year earlier.

Analysts surveyed by Capital IQ expected $5.25.

Revenue for the quarter ended Sept. 28 was $10.60 billion, compared with $10.57 billion a year earlier.

Analysts surveyed by Capital IQ expected $10.63 billion.

The company updated its 2024 adjusted EPS guidance to a range of $21.35 to $22.07 from the prior outlook of $21.29 to $22.07. Analysts polled by Capital IQ expect $21.72.

Revenue guidance is still projected to be $42.4 billion to $43.3 billion. Analysts polled by Capital IQ expect $42.92 billion.

Price: 582.93, Change: -3.45, Percent Change: -0.59